"instanceType","id","name","label","text","uuid:ID","identifier","description"
"EligibilityCriterion","EligibilityCriterion_1","Age Criteria","","Subjects shall be between [min_age] and [max_age]","a541aa2b-1c61-4934-89ce-f1e2c8c3cbfd","1","The study age criterion"
"EligibilityCriterion","EligibilityCriterion_2","Pop Criteria","","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)","336d4d4f-3f51-4257-bdd1-74df59fa02d9","2","The study population criterion"
"EligibilityCriterion","EligibilityCriterion_3","Diag Criteria","","[Activity1] score of 10 to 23","fb68031f-fb93-4299-be1d-a9aa9267a178","3","The study diagnosis criterion"
"EligibilityCriterion","EligibilityCriterion_4","Previous Criteria","","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline.","08efa28a-778c-4495-bdf3-807efb29d89d","9","The previous xanomeline TTS criterion"
